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Better prepare for the next one. Lifestyle lessons from the COVID-19 pandemic
Scientific journals are being publishing research articles on Severe
Acute Respiratory Syndrome Associated Coronavirus (SARS-CoV) since
2003. As an example, Web of Science currently collects almost 3,500
publications, many from 2004, 2005, 2006, then gradually declining
with a nadir in 2014. In 2020, we are witnessing a large publication
rebound.
It is clear that the scientific knowledge accumulated during these
years has not been useful in avoiding the current SARS-CoV-2 (COVID-
19) pandemic, either by not providing the necessary solutions or be-
cause the rulers, whose responsibility is to protect health and well-
being of their people, have not been aware of some useful information
likely disseminated among the aforementioned 3,500 publications.
This is the right time to better shape our future health. While so-
cieties around the world are fighting the virus and healthcare systems
are desperately caring for the sick to try to prevent them from dying, we
should think about the future, which will be just as troubling as the
present if we don't prepare for similar public health emergencies.
Unfortunately, to date, confinement is the best tool we have to stop
the COVID-19 pandemic, a clear indicator of the impotence of modern
medicine. Pandemics such as this one are commonplace in human
history and we will not avoid future ones.
Confinement profoundly modifies the behavior and, therefore, the
habitual lifestyles of individuals and communities, in restrictive terms.
The COVID-19 pandemic has caused people to be exposed to adverse
environmental conditions, not previously experienced. This brings
about relevant stress, whose health consequences are yet to be eluci-
dated [1,2]. Among the main consequences of confinement are noxious
conditions such as the lack of positive relationships and interactions; of
physiological stimuli; of objectives and goals to be achieved; of creative
ideas and opportunities; of changes in chronobiological rhythms and
perceptions; of air quality (often for the better); feelings of anxiety and
fear; and very importantly, functional and metabolic impairments dic-
tated by a sedentary lifestyle. These effects are slowly evolving and,
hence, it is difficult to imagine what their future consequences will be.
Changes in the neuroendocrine and immune setting produce adaptive
and compensatory responses the effects of which last for months, may
be for generations (epigenetics changes generated through major nu-
tritional and lifestyle challenges, such as severe malnutrition or tobacco
smoking in women, have been evoked as the cause behind the asso-
ciation with higher incidence of chronic diseases, such as diabetes and
cardiovascular diseases, through two or more generations [3]). In other
words, these changes in lifestyles occur now, during this phase of
Covid-19 pandemics, but their effects are expected to translate into
physical and psychological consequences that will last for a long time
after the crisis, potentially representing an emergency in the emergency
worth considering for its impact on health systems as well as on social
and financial policies of the different regions.
Unlike the seasonal viral infections responsible for influenza epi-
demics that have accustomed us to consider vaccines as a safe and
timely solution, or other infections such as HIV or hepatitis C that we
treat with state-of-the-art antiviral agents, COVID-19 and its respiratory
aftermaths must be considered as potentially incurable. In fact, during
the relatively short evolution of this pandemic, it has not yet been
possible to develop a vaccine or identify truly effective drugs against
this virus.
Of the epidemiological characteristics of this infection, greater in-
cidents and risks to human health are observed in adults over 65 years
of age with concomitant pathologies and in the frail elderly. Frailty can
be multifaceted, but we must keenly analyze sub-optimal lifestyles as
associated with age [4]. Indeed, it is quite clear that passive protection
measures designed to physically reduce exposure to the viral agent are
not sufficient to face an emergency scenario like the current one and its
"long wave" of health effects. Therefore, proactive measures are ne-
cessary based on the definition of protection and prevention strategy
that allows counteracting infections with an optimal state of health,
from the immunity point of view.
Healthy lifestyles and nutrition are crucial to augment the immune
system (immune-fitness) and, therefore, to effectively respond to viral
infections; repair the inflammatory and degenerative lesions that they
generate in the respiratory tract; and restore homeostasis of the meta-
bolic processes and the immune system itself [5]. In this context, im-
muno-protection is the cornerstone of medical practice and should not
be overlooked in either the presence and the absence of threats like the
one we face today. The preservation of the immune system must be a
strategic measure of public health and a priority issue of research po-
licies as well as of social and clinical management of lifespan extension
worldwide.
Healthy aging policies must aim at reducing chronic diseases,
mental health disorders, disability, and frailty. This requires that in-
frastructures and economic and social determinants of health be im-
plemented, for example, through greater investment in educational
programs and social services that lead to the necessary changes of
lifestyles. The advent of breakthrough information-communication
technologies and artificial intelligence in the last decades facilitates the
process also paving the way to other waves of innovations to face this
and other societal challenge of the “aging” era.
How can we improve our lifestyles and act proactively to strengthen
the immune system and, therefore, prepare for future, unavoidable
infections with the best of our immune potential?
We can think of using two tools: classic nutrition and precision
nutrition.
Classic nutrition factors include:
1 Protein energy malnutrition
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2 Specific deficiencies of micronutrient vitamins
3 Sedentary lifestyle, overweight-obesity and metabolic diseases.
4 Exposure to environmental immuno-interfering factors (tobacco
smoke, alcohol consumption, substances of abuse and drugs, en-
vironmental pollutants, and others)
Precision nutrition is now moving the attention to molecular aspects
of the discipline to embody the “P4” concept of modern medicine
(predictive, preventative, personalized, participatory). This is a para-
digm revolution in human nutrition that will benefit of a new genera-
tion of omics techniques that surely will innovate, possibly rewriting,
the nutritional approaches to successful aging and immunoprevention
strategies.
Some examples of these items include:
1 Protein energy malnutrition (PEM). The risk of developing this
condition increases with age and becomes particularly high in
conditions of severe illness and immobilization or significant re-
duction in physical activity. The presence of PEM increases the risk
of frailty in the elderly and, therefore, of severe comorbidity and
death. This picture is generally associated with severe alterations of
the immune response that begin with a reduction in the number of
white blood cells (leukopenia), which, together with serum albumin
levels, is one of the main indicators of PEM; at the somatic level, the
main indicator of PEM is a reduction in lean body mass, that is,
muscle mass. The latter becomes particularly apparent as a reduc-
tion in the musculature of some parts of the body, such as the
muscles of the leg and in particular of the thigh or the quadriceps;
also, those of the arms and trunk can rapidly suggest an onset of the
phenomenon. This process denotes an alteration of the metabolic
and energy management processes (metabolic reprogramming) that
lead to the use of muscle and other tissue proteins as energy source
rather than as functional components (for example, as a support for
muscle contraction). This occurs because the physiological processes
nutrient (particularly glucose) use for energy – in the presence of
altered insulin function – taper off. This energy reprogramming is
one of the main endocrine consequences and aging and its sequelae
accelerate in case of chronic inflammation (microinflammation) and
immunocompromise [6].
2 Micronutrient and vitamin deficiency. The importance of nutritional
factors and, in particular, of some micronutrients to guarantee an
optimal function of the immune system is well known [7]. Specific
deficiencies of vitamins and trace elements with a marked im-
munomodulatory action are observed in Western countries and, in
particular, in the elderly. In Spain and Italy, one of the countries that
should theoretically follow ideal lifestyles (those part of the Medi-
terranean Diet), the same deficiencies of other Western countries are
now observed, consequent to the globalization of food production
and supply systems [8,9]. These unavoidable developments reduce
the consumption of nutritional factors with a positive action on the
immune system, while providing an excess of caloric intake and,
therefore, higher risk of developing overweight, obesity, and me-
tabolic diseases that, in turn, promote secondary immunodeficiency
conditions. In summary, the Mediterranean and Western diets are
now often high in calories and low in micronutrients, a condition
that can lead to malnutrition, similar to that described above for
protein [10]. Vitamins such as A, B6, B12, C, D, E and folic acid and
minerals like zinc, iron, selenium, magnesium and copper are factors
and cofactors of many enzymes involved in immune processes. In
addition, they participate in the production of antimicrobial pro-
teins and in the activity of cells such as neutrophils and macro-
phages. Fatty acids of the omega 3 series, which are essential, are
the precursors of many molecules, e.g. resolvins, proteins and
maresins, that accelerate the resolution of inflammatory processes
[11].
3 Sedentary lifestyle, overweight/obesity, and metabolic diseases.
Sedentary lifestyles and obesity are important risk factors for the
development of cardiometabolic diseases and for an accelerated
decrease in immunoinflammatory homeostasis in all age groups,
particularly in the elderly. The last phenomenon - called im-
munosenescence - is responsible for the increased susceptibility to
infectious diseases seen in those over 65 years of age [12].
4 Exposure to environmental immune interference. There are nu-
merous environmental factors responsible for immunosuppression,
whose actions add to those of aging, and which might lead to the so-
called forms of secondary immunodeficiency [13]. Recently, the
importance of epigenetic factors is emerging, in particular, in their
relevance to the susceptibility to viral infections.
5 Intestinal dysbiosis. A healthy microbiota contributes to the main-
tenance of the immune system, much of which contributes to the
immune response through B and T cells. To corroborate this theory,
2 to 10% of Chinese SARS-Cov patients experienced gastrointestinal
symptoms at start [14]. Coronaviruses, including Covid-19, bind to
the angiotensin-converting enzyme 2 (ACE2) from the intestinal
epithelium and use it as a receptor. The intensity of this link seems
to be related to the state of health of the intestinal microbiota.
Physicians should be aware that provision of selected probiotics
might strengthen the immune response, although full confirmation
by human trials is still needed [15,16].
6 Parallel to the development of precision therapies in medicine,
precision nutrition is an emerging science that is based on well-es-
tablished factors such as genetic, epigenetic, and microbiome in-
dividual variations [17]. Numerous molecular studies are providing
mechanistic insight into precision nutrition. As very specific ther-
apeutic objectives must be achieved, precision nutrition must be
based on food products with well-established mechanisms of action
at the molecular level in terms of gene expression and modulation,
and signaling pathways. This includes modulating the response of
the immune system through activation of innate immune responses,
considering that personal genetic profiles affect immune variables.
We believe it important that future studies include the verification
of the nutritional status of the subjects before interventions, via the
development of screening tests with reliable protocols and indicators,
using omics techniques. These indicators should include both PEM and
vitamin status, with complete metabolic and transcriptomic panels
dedicated to the expected immune response of the intervention [18].
This approach should also be used for the microbiome and lipidome and
for the assessment of genetic profiles.
Paying more attention to the introduction of micronutrients and
vitamins is the only immunoprotection strategy we have available and
for which there is sufficient evidence available on both the effectiveness
and safety of the intervention. The recommended protocol includes
optimizing the consumption of these compounds, particularly by the
elderly and by pregnant women, in whom the epigenetic effects may be
more pronounced. In some cases, the possibility of supplementation,
particularly with vitamin D (which is synthesized by sun exposure,
often insufficient during the winter season); with long-chain omega 3
fatty acids in subjects who do not usually consume fish; vitamin C to
ensure intakes of 200mg/d (maximum bioavailability); and appro-
priate probiotics to maintain a state of eubiosis.
Obviously, this strategy must be combined with healthy lifestyles, a
balanced diet, regular physical activity and a reduction in exposure to
other environmental factors with a negative effect on immunity and,
more generally, on human health (described above). The possibility of
obtaining a positive synergy in the effects of these interventions is very
high and should be considered as an urgent measure that should be
taken together with the others identified to date. We hope that this
COVID-19 crisis will change the priorities of humanity and society and
that we can take this opportunity to foster research aimed at guiding
public health policies. Will we be ready next time?
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